Researchers looking to buy SARMs (Selective Androgen Receptor Modulators) for preclinical investigation will find a diverse class of synthetic compounds studied for tissue-selective androgen receptor activity. SARMs were developed with the goal of achieving anabolic effects in skeletal muscle and bone — mechanisms relevant to muscle wasting, osteoporosis, and androgen deficiency research — while minimising androgenic activity in prostate, skin, and other androgen-sensitive tissues. EdgeChems supplies research-grade SARMs for sale including RAD-140, YK-11, S-23, S-4 Andarine, and AC-262,536, all HPLC-verified at ≥98% purity.

How SARMs Work: Selective Androgen Receptor Modulation

The androgen receptor (AR) is a nuclear transcription factor activated by androgens — testosterone, DHT, and their synthetic analogues. Traditional anabolic steroids activate the AR non-selectively across all androgen-sensitive tissues, producing desired anabolic effects alongside undesired androgenic effects (prostate hypertrophy, alopecia, virilisation). SARMs were designed to exploit differential AR coactivator recruitment in different tissues — binding the AR but inducing different conformational changes than testosterone, leading to different gene expression profiles depending on which coactivators are present in a given tissue type.

The tissue selectivity model predicts that SARMs can activate AR-driven anabolic pathways in muscle and bone while acting as partial agonists or antagonists in prostate and skin. In practice, selectivity profiles vary significantly between different SARMs — and all findings remain preclinical.

RAD-140 (Testolone)

RAD-140 is one of the most potent SARMs in preclinical research, developed by Radius Health. In animal models, RAD-140 shows high anabolic activity (comparable to testosterone) with significantly reduced androgenic activity at the prostate. It also shows neuroprotective properties in some neural cell models — an unusual profile that has attracted research interest beyond the traditional muscle/bone application area. Buy RAD-140 for sale from EdgeChems.

YK-11

YK-11 occupies a unique position in SARM research because it is also a potent myostatin inhibitor. Myostatin (GDF-8) is a TGF-beta family member that limits muscle growth — its inhibition produces dramatic muscle hypertrophy in animal models. YK-11 activates the AR and simultaneously inhibits myostatin signalling, studied for a dual anabolic mechanism not seen in other SARMs. Buy YK-11 for sale from EdgeChems.

S-23

S-23 is a highly potent, non-steroidal SARM investigated primarily in male contraceptive research as well as muscle and bone anabolism studies. In animal models, S-23 suppresses spermatogenesis at specific doses while maintaining anabolic activity — making it one of the few research SARMs studied for hormonal contraceptive applications. At lower doses, it is studied for anabolic activity with reduced androgenic profile. Buy S-23 for sale from EdgeChems.

S-4 (Andarine)

S-4 (Andarine) is one of the earlier SARMs developed by GTx Inc., with an extensive preclinical track record in muscle and bone research. Animal studies show S-4 increases bone mineral density and muscle mass in castrate rodent models, with significantly reduced prostate stimulation versus testosterone. Andarine’s well-characterised pharmacokinetics and established research literature make it a common reference compound in SARM pharmacology studies. Buy S-4 Andarine for sale from EdgeChems.

AC-262,536

AC-262,536 is a non-steroidal SARM developed by Acadia Pharmaceuticals, investigated for partial AR agonism with high selectivity for anabolic over androgenic activity. In animal models, AC-262,536 shows approximately 66% of testosterone’s anabolic activity in muscle while producing only about 27% of testosterone’s androgenic activity at the prostate — among the better selectivity ratios in the SARM class. It has also been studied in prostate cancer models, where its partial agonism may paradoxically serve a research function different from full agonists. Buy AC-262,536 for sale from EdgeChems.

SARM Research Safety Considerations

All SARMs are investigational compounds. None are approved for human therapeutic use by the FDA or any comparable regulatory body. Preclinical hepatotoxicity signals have been observed with some SARM compounds in animal studies, and limited case reports in the clinical literature describe liver enzyme elevations in individuals who self-administered SARMs obtained from unverified sources. These safety signals underscore the importance of HPLC-verified purity in research compounds — impure preparations or incorrectly identified compounds represent confounding variables in any research protocol and pose additional safety unknowns.

Product Specifications

For research purposes only. Not intended for human or veterinary use. All information is presented for scientific reference.